Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Loading...
Community
/
Sweden
/
Pharmaceuticals & Biotech
/
Biotage
Create a narrative
Biotage Community
OM:BIOT Community
1
Narratives
written by author
0
Comments
on narratives written by author
11
Fair Values set
on narratives written by author
Community Investing Ideas
Biotage
Popular
Undervalued
Overvalued
Biotage
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Bioprocessing And Peptide System Capacity Improvements Will Create Future Opportunities
Key Takeaways Bioprocessing expansion and improved cost management are driving revenue growth while enhancing operational efficiency and profitability. Focus on pipeline management and capacity expansion could boost visibility and unlock significant future revenue opportunities.
View narrative
SEK 143
FV
0.1% overvalued
intrinsic discount
0.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
about 2 months ago
author updated this narrative